definiens: as that term is defined in 21 C.F.R. § 314.3(b ) ( or any analogousApplicable Law recognized outside of the United States ), to data ( including any regulatory filings)owned, possessed or otherwise Controlled by Licensee or its Affiliates as of the effective date oftermination to the extent such relates to the Compound or any Licensed Product in the Field in theTerritory for the purposes of obtaining and maintaining Regulatory Approval for Licensed Products inthe Field in the Territory, and Licensee will provide a signed statement to this effect, if requested byOSI, in accordance with 21 C.F.R. § 314.50(g)(3 ) ( or any analogous law outside of the United States ) ; 26 ( d ) the Parties shall cooperate to transfer any ongoing Clinical Trials in the Territory(including any Clinical Trials initiated following Regulatory Approval and any patient registry or othercollection of patient data ) in an orderly manner to OSI as promptly as reasonably practicable followingsuch termination or expiration, with each Party bearing its own costs in relation to such transfer . Priorto the completion of such transfer, Licensee shall continue at its expense to conduct such ClinicalTrials in a manner designed to avoid any disruption of or delay in the completion of any such ClinicalTrial ; ( e ) To the extent that, as of the effective date of termination of this Agreement, Licensee, its Affiliates or Sublicensees has existing and ongoing contracts with Third Parties relatedto the Development, Manufacture or Commercialization of any Licensed Product(s ), at the writtenrequest of OSI, Licensee will use, and will cause its Affiliates and Sublicensees to use, good faithcommercially reasonable efforts to transfer such contracts and arrangements to OSI, including usinggood faith commercially reasonable efforts to assign contracts and arrangements to OSI in part orfacilitate separate arrangements with OSI if such contracts and arrangements relate to more thansolely the Licensed Product(s ) ; ( f ) With respect to quantities of Licensed Product not sold by Licensee under Section8.7.3, at OSI ’s written request, Licensee shall deliver such quantities of the applicable LicensedProduct(s ) that Licensee or any of its Affiliates has in its respective inventory or control ( includinginventory in its control on the premises of a Third Party subcontractor ) as of the date of OSI’srequest and OSI shall reimburse Licensee at Licensee ’s reasonable cost of goods for such LicensedProduct(s ) ; ( g ) Licensee shall supply to OSI such reasonable quantities of Licensed Product(s ) asOSI indicates in written forecasts and orders from time to time, until the earlier of ( i ) such time asOSI has established an alternative, validated source of supply for such Licensed Product(s ) and ( ii)the second anniversary of the effective date of termination of this Agreement . The costs to OSI forsupply of such Licensed Product(s ) from Licensee shall be equal to Licensee ’s reasonable cost ofgoods for such Licensed Product(s ) . Notwithstanding anything to the contrary in this Agreement, ifany such Licensed Product is manufactured for Licensee by a Third Party contract manufacturerpursuant to a written contract, then Licensee may satisfy its obligations pursuant to this Section8.7.5(g ) with respect to such Licensed Product by assigning its rights and obligations under suchcontract ( or the portion of such contract pertaining to such Licensed Product ) to OSI ; and 27 ( h ) Licensee shall for one ( 1 ) year from the effective date of termination, at the writtenrequest and expense of OSI, provide OSI with such assistance as is reasonably necessary toeffectuate a smooth and orderly transition to OSI or its designee of any Development, Manufactureand Commercialization activities relating to the applicable Licensed Product(s ) so as to minimize thedisruption of such activities, provided, however, that Licensee shall not be obligated to initiate anynew substantive activity, distinct from any previously ongoing substantive activity, that would itselfcreate any new obligations on the part of Licensee that would continue following such termination